Pershing Square's Bill Ackman may have made a killing on Allergan (NYSE: AGN) following its sale to Actavis (NYSE: ACT) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE